Viome Life Sciences raises $54M for expanded clinical trials
Mobi Health News
NOVEMBER 10, 2021
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
Let's personalize your content